Relx Plc (NYSE:RELX) Short Interest Down 13.1% in February

Relx Plc (NYSE:RELX – Get Rating) saw a significant decline in short interest during the month of February. As of February 28th, there was short interest totalling 1,190,000 shares, a decline of 13.1% from the February 13th total of 1,370,000 shares. Based on an average trading volume of 786,300 shares, the short-interest ratio is currently 1.5 days. Currently, 0.1% of the shares of the stock are sold short.

Relx Stock Performance

Shares of NYSE RELX opened at $30.07 on Friday. The firm has a 50 day moving average price of $29.50 and a 200 day moving average price of $27.58. The company has a debt-to-equity ratio of 1.56, a quick ratio of 0.53 and a current ratio of 0.59. Relx has a 52-week low of $23.39 and a 52-week high of $32.24.

Relx Increases Dividend

The company also recently disclosed a Semi-Annual dividend, which will be paid on Monday, June 12th. Investors of record on Friday, April 28th will be issued a dividend of $0.466 per share. The ex-dividend date of this dividend is Thursday, April 27th. This is a boost from Relx’s previous Semi-Annual dividend of $0.44.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the stock. Credit Suisse Group boosted their target price on shares of Relx from GBX 2,800 ($33.67) to GBX 2,860 ($34.39) in a research note on Friday, February 17th. Barclays cut shares of Relx from an “overweight” rating to an “equal weight” rating in a research report on Tuesday, January 31st. StockNews.com initiated coverage on shares of Relx in a research report on Wednesday, November 30th. They set a “hold” rating for the company. Morgan Stanley lowered their price target on shares of Relx from GBX 3,020 ($36.32) to GBX 2,950 ($35.47) in a research report on Friday, December 16th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Relx from GBX 2,730 ($32.83) to GBX 2,810 ($33.79) in a research report on Thursday, January 26th.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of RELX. Resurgent Financial Advisors LLC acquired a new position in Relx during the fourth quarter valued at approximately $27,000. CoreCap Advisors LLC bought a new position in Relx in the second quarter valued at approximately $28,000. Allworth Financial LP lifted its stake in Relx by 455.3% in the third quarter. Allworth Financial LP now owns 1,455 shares of the technology company’s stock valued at $35,000 after buying an additional 1,193 shares in the last quarter. Pinnacle Bancorp Inc. bought a new position in Relx in the third quarter valued at approximately $35,000. Finally, Penserra Capital Management LLC bought a new position in Relx in the third quarter valued at approximately $36,000. Institutional investors and hedge funds own 3.41% of the company’s stock.

Relx Company Profile

(Get Rating)

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.